Episode Details

Back to Episodes

E79: Mary Huckle (RIP 3/06/2023)- Living With a Secondary Cancer Diagnosis

Episode 79 Published 3 years, 1 month ago
Description

**TRIGGER WARNING**

Naman Julka-Anderson and Jo McNamara catch up with Mary Huckle as part of the Living With and Beyond Cancer Series (Part 23).

Discussion about Mary’s experience of living with secondary cancer, METUPUK and Mary’s advocacy work.

Mary Huckle 11/9/1965 - 3/6/2023 RIP.

 

To use this podcast as CPD, look at these reflection points: 

1) Reflect upon the support systems in place in your area for patients receiving treatment for secondary breast cancer? 

2) Reflect upon how the advice and support you give patients with secondary cancer may differ. Do you personlise your advice and support for these patients?


Complete this form for your accredited digital badge: https://bit.ly/3GbtR1X.

Links from podcast:

METUPUK: https://metupuk.org.uk/ 

Make 2nds Count: https://www.make2ndscount.co.uk/ 

Please like and subscribe to Rad Chat on your podcast library.


Our links:

Link Tree: https://linktr.ee/radchat 

Facebook: https://www.facebook.com/RadChatPodcast/ 

Instagram: https://www.instagram.com/rad__chat/ 

LinkedIn: https://uk.linkedin.com/company/radtalk 

Tik Tok: https://www.tiktok.com/@rad_chat 

Twitter: https://twitter.com/rad__chat?lang=en 

© Rad Chat 2025. All rights reserved.  

We (or our licensors) own all intellectual property rights in this podcast and all related content, online and offline.  

You may not use, copy, modify, download, archive, reproduce, distribute, display, publish, licence, create derivative works from or commercially exploit any part of our content unless we expressly agree in writing.  

You must not use any images, audio, video, graphics or clips separately from their accompanying context.  

Please acknowledge Rad Chat (and any identified contributors) clearly whenever referencing or sharing our content.

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us